[1]
A. Kogge, “Vorinostat for Refractory or Relapsing Epidermotropic T-cell Lymphoma: A Retrospective Cohort Study of 15 Patients”, Acta Derm Venereol, vol. 95, no. 1, pp. 72–77, May 2014.